“Drying of Opzelura® (Ruxolitinib) Cream 1.5%: Implications for Clinical and Real-World Use”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 6, Nov. 2024, p. s454, https://doi.org/10.25251/skin.8.supp.454.